Dr Lucy Mackillop
Contact information
Roles
- Consultant Obstetric Physician, Oxford University Hospitals NHS Foundation Trust
- President of MacDonald Obstetric Medicine Society
- Chair of the RCP/MOMs Joint Committee for Obstetric Medicine
- Advisor to NICE and MHRA
- NIHR reviewer
- MBRRACE-UK reviewer and chapter writer
- APEC Trustee
- Executive member of International Society of Obstetric Medicine
- Chief Medical Officer – Data & Research EMIS Group Ltd
- Co-Inventor and clinical lead for GDm-Health™ – licensed to Sensyne Health, now owned by Huma
Lucy Mackillop
BM BCh MA (Oxon.) FRCP, FRCOG ad Eundem
Honorary Senior Clinical Lecturer
Biography
Dr Mackillop is a Consultant Obstetric Physician, Oxford University Hospitals NHS Foundation Trust; Honorary Senior Clinical Lecturer, Nuffield Department of Women’s and Reproductive Health, University of Oxford; Fellow of both the Royal College of Physicians and Royal College of Obstetricians and Gynaecologists; President of the UK’s MacDonald Obstetric Medicine Society and Chief Medical Officer – Data & Research at EMIS Ltd.
Dr Mackillop trained in General, Renal and Obstetric Medicine in Oxford, London and Sydney before taking up her consultant post in 2008.
Dr Mackillop has published over 90 peer-reviewed articles, national and international guidelines, book chapters and e-learning resources on a wide variety of medical conditions in pregnancy. She is Chair for the Joint Committee for Obstetric Medicine with The Royal College of Physicians (RCP) and co-wrote the RCP’s curriculum for the diploma in Obstetric Medicine.
Her research interests include the role of remote monitoring solutions in women with medical problems in pregnancy and construction of evidence-based algorithms to predict acutely unwell women in pregnancy and the immediate puerperium.
She led the development and evaluation of a patient app-to-clinician digital system (GDm-Health) for the management of women with diabetes in pregnancy through to commercialisation and scale; now used in over half of maternity units in England.
She leads the Data and Research strategy for EMIS Ltd, the largest provider of clinical systems in primary care in the UK.
Recent publications
-
REduced‐Carbohydrate intervention for managing Obesity and Reduction of gestational Diabetes (RECORD): A randomized controlled feasibility trial
Journal article
Michalopoulou M. et al, (2024), Diabetes, Obesity and Metabolism
-
Direct current cardioversion in pregnancy: a multicentre study.
Journal article
Cauldwell M. et al, (2023), BJOG, 130, 1269 - 1274
-
A Deep Learning Approach of Blood Glucose Predictive Monitoring for Women with Gestational Diabetes
Preprint
Lu H. et al, (2023)
-
Digital Health and Machine Learning Technologies
for Blood
Glucose Monitoring and Management of Gestational Diabetes
Journal article
Lu HY. et al, (2023), IEEE Reviews in Biomedical Engineering
-
Prevalence of pre-eclampsia and adverse pregnancy outcomes in women with pre-existing cardiomyopathy: a multi-centre retrospective cohort study.
Journal article
Ormesher L. et al, (2023), Sci Rep, 13
-
AI in Obstetrics Gynaecology
Chapter
Mathewlynn S. and Mackillop L., (2023), AI in Clinical Medicine: A Practical Guide for Healthcare Professionals, 239 - 252
-
Experience and opinions relating to pregnancy in patients with chronic intestinal failure: an international survey.
Journal article
Bond A. et al, (2023), Frontline Gastroenterol, 14, 377 - 383